Akitoshi Hakoda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Akitoshi Hakoda has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
Hiroki Nishikawa
The Second Department of Internal Medicine, Osaka Medical Pharmaceutical University, Osaka, Japan
7 shared publications- Kazuhiro Ota
Second Department of Internal Medicine Osaka Medical and Pharmaceutical University Osaka Japan
6 shared publications - Takeshi Ogura
Osaka Medical and Pharmaceutical University, Osaka Prefecture, Japan
6 shared publications - Taro Iwatsubo
Second Department of Internal Medicine Osaka Medical and Pharmaceutical University Takatsuki Osaka Japan
6 shared publications - Noriaki Sugawara
Second Department of Internal Medicine Osaka Medical and Pharmaceutical University Osaka Japan
4 shared publications Shun Sasaki
Endoscopy Center, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan
4 shared publications
Latest Publications
- 29 July 2026
- Published by Georg Thieme Verlag KG in Endoscopy
The effect of spiral basket geometry on procedural efficiency and device escalation in small bile duct stones: a multicenter randomized controlled trial (ESCAPE trial)
The optimal first-line device for endoscopic retrograde cholangiopancreatography (ERCP) removal of small common bile duct stones (CBDS) remains uncertain. Whether basket geometry – independent of device category – influences procedural efficiency has not been evaluated in a randomized trial. We aimed to compare a spiral-configured 8-wire basket with a standard 8-wire basket for small CBDS. In this multicenter randomized controlled trial, patients with CBDS ≤8 mm were randomly assigned (1:1) to stone extraction using a standard or spiral-configured 8-wire basket. Among 200 randomized patients, 193 underwent basket insertion (spiral group 97, standard group 96). First-line procedural success without device escalation within 10 minutes was significantly higher in the spiral group (97.9% vs. 85.4%; 95%CI 4.9 to 20.1; P = 0.004), corresponding to a number-needed-to-treat of 8. The spiral basket required fewer sweeps (mean [SD]: 2.71 [1.41] vs. 3.31 [1.67]; P = 0.01) and shorter procedure time (3.96 [2.86] vs. 5.48 [4.38] minutes; P = 0.01). Adverse event rates were comparable between groups. Mean device-related costs were lower in the spiral group (mean difference –108 USD; bootstrap 95%CI –185 to –42). A spiral basket configuration improved early procedural efficiency and reduced device escalation and device-related costs, without improving the final stone clearance rate or increasing adverse events. The spiral basket was not compared with balloon extraction and should not be interpreted as superior to it. Although the device evaluated is currently available primarily in Japan, the geometric principle underlying its advantage may inform device development more broadly.
- 29 July 2026
- Published by Georg Thieme Verlag KG in Endoscopy
The effect of spiral basket geometry on procedural efficiency and device escalation in small bile duct stones: a multicenter randomized controlled trial (ESCAPE trial)
The optimal first-line device for endoscopic retrograde cholangiopancreatography (ERCP) removal of small common bile duct stones (CBDS) remains uncertain. Whether basket geometry – independent of device category – influences procedural efficiency has not been evaluated in a randomized trial. We aimed to compare a spiral-configured 8-wire basket with a standard 8-wire basket for small CBDS. In this multicenter randomized controlled trial, patients with CBDS ≤8 mm were randomly assigned (1:1) to stone extraction using a standard or spiral-configured 8-wire basket. Among 200 randomized patients, 193 underwent basket insertion (spiral group 97, standard group 96). First-line procedural success without device escalation within 10 minutes was significantly higher in the spiral group (97.9% vs. 85.4%; 95%CI 4.9 to 20.1; P = 0.004), corresponding to a number-needed-to-treat of 8. The spiral basket required fewer sweeps (mean [SD]: 2.71 [1.41] vs. 3.31 [1.67]; P = 0.01) and shorter procedure time (3.96 [2.86] vs. 5.48 [4.38] minutes; P = 0.01). Adverse event rates were comparable between groups. Mean device-related costs were lower in the spiral group (mean difference –108 USD; bootstrap 95%CI –185 to –42). A spiral basket configuration improved early procedural efficiency and reduced device escalation and device-related costs, without improving the final stone clearance rate or increasing adverse events. The spiral basket was not compared with balloon extraction and should not be interpreted as superior to it. Although the device evaluated is currently available primarily in Japan, the geometric principle underlying its advantage may inform device development more broadly.
- Open Access
- 3 April 2026
- Published by Wolters Kluwer Health in Endoscopic Ultrasound
- Vol. 15 (1) , 49-56
Prospective evaluation study of EUS-guided hepaticogastrostomy without tract dilation: Comparison to with tract dilation
Background and Objectives: During EUS–guided hepaticogastrostomy (EUS-HGS), bile leak usually occurs in the interval between tract dilation and stent deployment. Recently, a novel partially covered self-expandable metal stent (PCSEMS) with fine gauge stent delivery system (5.9Fr) has become available. Therefore, the aim of this prospective study was to evaluate the technical feasibility of EUS-HGS using this novel stent without tract dilation and compare it with EUS-HGS with tract dilation. Method: Patients with biliary disease who required EUS-BD were eligible for enrollment in this study. The primary outcome was the technical success rate of stent deployment without tract dilation. Results: The technical success rate of the one-step technique was 92.0% (23/25). Mean procedure time was 10.1 min, and the clinical success rate was 96% (24/25). As adverse events, bile peritonitis and stent migration were observed in one patient each. As historical controls, 75 patients who underwent EUS-HGS were enrolled in this study. As adverse events, bile peritonitis was observed in eight patients and cholangitis in three patients. After propensity score matching analysis, procedure time was significantly shorter in the one-step group compared with the two-step group (9.84 vs . 19.0 min, P < 0.001). In addition, bile peritonitis as an adverse event was significantly more frequent in the two-step group than the one-step group ( P = 0.018). Conclusions: In conclusion, EUS-HGS using this novel PCSEMS might be feasible and safe, and performance of tract dilation might influence the occurrence of bile peritonitis.
- 3 April 2026
- Published by Wolters Kluwer Health in Endoscopic Ultrasound
- Vol. 15 (1) , 49-56
Open AccessProspective evaluation study of EUS-guided hepaticogastrostomy without tract dilation: Comparison to with tract dilation
Background and Objectives: During EUS–guided hepaticogastrostomy (EUS-HGS), bile leak usually occurs in the interval between tract dilation and stent deployment. Recently, a novel partially covered self-expandable metal stent (PCSEMS) with fine gauge stent delivery system (5.9Fr) has become available. Therefore, the aim of this prospective study was to evaluate the technical feasibility of EUS-HGS using this novel stent without tract dilation and compare it with EUS-HGS with tract dilation. Method: Patients with biliary disease who required EUS-BD were eligible for enrollment in this study. The primary outcome was the technical success rate of stent deployment without tract dilation. Results: The technical success rate of the one-step technique was 92.0% (23/25). Mean procedure time was 10.1 min, and the clinical success rate was 96% (24/25). As adverse events, bile peritonitis and stent migration were observed in one patient each. As historical controls, 75 patients who underwent EUS-HGS were enrolled in this study. As adverse events, bile peritonitis was observed in eight patients and cholangitis in three patients. After propensity score matching analysis, procedure time was significantly shorter in the one-step group compared with the two-step group (9.84 vs . 19.0 min, P < 0.001). In addition, bile peritonitis as an adverse event was significantly more frequent in the two-step group than the one-step group ( P = 0.018). Conclusions: In conclusion, EUS-HGS using this novel PCSEMS might be feasible and safe, and performance of tract dilation might influence the occurrence of bile peritonitis.
- Open Access
- 1 March 2026
- Published by Wolters Kluwer Health in Endoscopic Ultrasound
- Vol. 15 (2) , 105-109
Time to endosonography-created route formation after EUS–guided hepaticojejunostomy for performing antegrade procedures
Background and Objectives: The antegrade procedure can be safely performed via an endosonography-created route (ESCR). Among the various types of surgically altered anatomy, antegrade procedures are frequently attempted in patients with Roux-en-Y (RY) anastomosis. For patients with RY anastomosis, EUS-guided hepaticojejunostomy (EUS-HJS) can be performed. However, evidence of the technical feasibility and safety of EUS-HJS is still limited, and there is no evidence of the time required for definitive formation of the ESCR after EUS-HJS. In the present study, we evaluated the time to formation of the ESCR after EUS-HJS for safely performing antegrade procedures. Method: Patients in whom EUS-HJS was attempted were eligible for study enrollment. The primary outcome of the present study was to evaluate the time to ESCR creation after EUS-HJS. This time was measured from the day of EUS-HJS to HJS stent removal. The technical success rates of EUS-HJS, HJS stent removal, the trans-ESCR procedure, and adverse events were secondarily evaluated. Results: A total of 42 patients were enrolled in the present study. The median interval prior to EUS-HJS stent removal was 10 days (range, 7–19 days). ESCR formation was confirmed in all patients who underwent EUS-HJS stent removal (100%, 42/42). The technical success rate of the subsequent trans-ESCR procedure was 95.2% (40/42). ESCR broken was not observed during procedures. Conclusions: In conclusion, sufficient formation of the ESCR for performing antegrade procedures might occur within 10 days after EUS-HJS in patients with RY anastomosis.
- 1 March 2026
- Published by Wolters Kluwer Health in Endoscopic Ultrasound
- Vol. 15 (2) , 105-109
Open AccessTime to endosonography-created route formation after EUS–guided hepaticojejunostomy for performing antegrade procedures
Background and Objectives: The antegrade procedure can be safely performed via an endosonography-created route (ESCR). Among the various types of surgically altered anatomy, antegrade procedures are frequently attempted in patients with Roux-en-Y (RY) anastomosis. For patients with RY anastomosis, EUS-guided hepaticojejunostomy (EUS-HJS) can be performed. However, evidence of the technical feasibility and safety of EUS-HJS is still limited, and there is no evidence of the time required for definitive formation of the ESCR after EUS-HJS. In the present study, we evaluated the time to formation of the ESCR after EUS-HJS for safely performing antegrade procedures. Method: Patients in whom EUS-HJS was attempted were eligible for study enrollment. The primary outcome of the present study was to evaluate the time to ESCR creation after EUS-HJS. This time was measured from the day of EUS-HJS to HJS stent removal. The technical success rates of EUS-HJS, HJS stent removal, the trans-ESCR procedure, and adverse events were secondarily evaluated. Results: A total of 42 patients were enrolled in the present study. The median interval prior to EUS-HJS stent removal was 10 days (range, 7–19 days). ESCR formation was confirmed in all patients who underwent EUS-HJS stent removal (100%, 42/42). The technical success rate of the subsequent trans-ESCR procedure was 95.2% (40/42). ESCR broken was not observed during procedures. Conclusions: In conclusion, sufficient formation of the ESCR for performing antegrade procedures might occur within 10 days after EUS-HJS in patients with RY anastomosis.
- Open Access
- 14 January 2025
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 57 (S 01) , E1357-E1358
Endoscopic closure of a refractory gastric fistula using a novel cap-assisted poly-glycolic acid sheet application method
Gastrointestinal perforations and fistulas are severe conditions requiring prompt treatment. Endoscopic closure of fistulas using a polyglycolic acid (PGA) sheet (Neoveal; Gunze Co., Kyoto, Japan) with fibrin glue is minimally invasive and effective treatment for these conditions [1] [2] [3]. However, for fistulas caused by peptic ulcers, it is desirable to cover not only the perforation but also the surrounding ulcerated area with a large sheet. The conventional method of PGA sheet application through the accessory channel of the endoscope for fistula closure is relatively simple; however, deploying the sheet endoscopically within the gastrointestinal tract can be time-consuming due to the difficulty in maintaining its planar shape. Patients with gastrointestinal perforations or fistulas often present in poor general conditions, necessitating rapid wound closure. To address this challenge, we developed the “Cap-PGA method (CPM),” a novel PGA sheet application technique utilizing a cap attached to the endoscope tip ([Fig. 1]). The CPM facilitates the release of the sheet that remains fully expanded within the gastrointestinal tract, thereby simplifying deployment and significantly reducing the procedural time. This method is also adaptable to larger sheets. We report the case of a 71-year-old female with a refractory gastric fistula secondary to a drug-induced gastric ulcer perforation, which was successfully closed using CPM ([Video 1]). The patient was undergoing immunosuppressive therapy. She developed a drug-induced gastric ulcer perforation, which was initially managed conservatively but resulted in a persistent fistula ([Fig. 2]). Conventional endoscopic PGA sheet application was attempted but failed because of dislodgement. Alternatively, we attempted to use the CPM. The PGA sheet was grasped using forceps passed through the working channel of the endoscope and positioned to cover the cap attached to the scope tip. The scope was then blindly introduced into the stomach, and the sheet was released. The sheet maintained its fully expanded shape upon release, allowing for easy application to the ulcer base and fistula ([Fig. 3], [Fig. 4]). No procedure-related complications occurred. The total procedural time from scope insertion to withdrawal was approximately 6 min. Ten days after the procedure, endoscopic contrast examination confirmed the successful closure of the fistula. CPM allows for rapid and relatively simple coverage of fistulas with PGA sheets. This technique may be an effective treatment, especially for ulcers, fistulas, and perforations that require larger PGA sheets. Endoscopy_UCTN_Code_TTT_1AO_2AI Article published online: 26 November 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 14 January 2025
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 57 (S 01) , E1357-E1358
Open AccessEndoscopic closure of a refractory gastric fistula using a novel cap-assisted poly-glycolic acid sheet application method
Gastrointestinal perforations and fistulas are severe conditions requiring prompt treatment. Endoscopic closure of fistulas using a polyglycolic acid (PGA) sheet (Neoveal; Gunze Co., Kyoto, Japan) with fibrin glue is minimally invasive and effective treatment for these conditions [1] [2] [3]. However, for fistulas caused by peptic ulcers, it is desirable to cover not only the perforation but also the surrounding ulcerated area with a large sheet. The conventional method of PGA sheet application through the accessory channel of the endoscope for fistula closure is relatively simple; however, deploying the sheet endoscopically within the gastrointestinal tract can be time-consuming due to the difficulty in maintaining its planar shape. Patients with gastrointestinal perforations or fistulas often present in poor general conditions, necessitating rapid wound closure. To address this challenge, we developed the “Cap-PGA method (CPM),” a novel PGA sheet application technique utilizing a cap attached to the endoscope tip ([Fig. 1]). The CPM facilitates the release of the sheet that remains fully expanded within the gastrointestinal tract, thereby simplifying deployment and significantly reducing the procedural time. This method is also adaptable to larger sheets. We report the case of a 71-year-old female with a refractory gastric fistula secondary to a drug-induced gastric ulcer perforation, which was successfully closed using CPM ([Video 1]). The patient was undergoing immunosuppressive therapy. She developed a drug-induced gastric ulcer perforation, which was initially managed conservatively but resulted in a persistent fistula ([Fig. 2]). Conventional endoscopic PGA sheet application was attempted but failed because of dislodgement. Alternatively, we attempted to use the CPM. The PGA sheet was grasped using forceps passed through the working channel of the endoscope and positioned to cover the cap attached to the scope tip. The scope was then blindly introduced into the stomach, and the sheet was released. The sheet maintained its fully expanded shape upon release, allowing for easy application to the ulcer base and fistula ([Fig. 3], [Fig. 4]). No procedure-related complications occurred. The total procedural time from scope insertion to withdrawal was approximately 6 min. Ten days after the procedure, endoscopic contrast examination confirmed the successful closure of the fistula. CPM allows for rapid and relatively simple coverage of fistulas with PGA sheets. This technique may be an effective treatment, especially for ulcers, fistulas, and perforations that require larger PGA sheets. Endoscopy_UCTN_Code_TTT_1AO_2AI Article published online: 26 November 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- Open Access
Novel gel‐immersion endoscopic injection sclerotherapy method for prophylactic hemostasis of esophageal varices: A pilot feasibility and safety study (with video)
Endoscopic injection sclerotherapy (EIS) is a useful prophylactic hemostatic procedure for esophageal varices. However, injecting sclerosing agents into blood vessels is technically challenging and often ineffective. Gel‐immersion EIS (GI‐EIS) may facilitate easier intravascular sclerosing agent injection by dilating the varices and enhancing scope stability by maintaining low intra‐gastrointestinal pressure. Therefore, we aimed to evaluate the effectiveness and safety of this procedure. This retrospective study included 18 patients (14 men and four women; median age, 70 years; age range, 18–83 years) who underwent GI‐EIS at Osaka Medical Pharmaceutical University Hospital between December 1, 2022, and January 30, 2024. Patients who were at least 18 years of age at the time of treatment were included. No patients were excluded from the study. Thirty‐four punctures were performed. The donor vessel angiography success rate was 88.2% (30 of 34 punctures). The clinical success rate was 94.4% (17 of 18 patients). Esophageal varices in most patients disappeared or were reduced by 1 month after treatment. Adverse events related to the procedure included fever (three patients) and chest pain (one patient); however, both were resolved with conservative treatment. No respiratory deterioration due to aspiration occurred during the procedure. The results of this study demonstrate that GI‐EIS is a safe, clinically feasible, and effective treatment option for prophylactic hemostasis of esophageal varices.
Open AccessNovel gel‐immersion endoscopic injection sclerotherapy method for prophylactic hemostasis of esophageal varices: A pilot feasibility and safety study (with video)
Endoscopic injection sclerotherapy (EIS) is a useful prophylactic hemostatic procedure for esophageal varices. However, injecting sclerosing agents into blood vessels is technically challenging and often ineffective. Gel‐immersion EIS (GI‐EIS) may facilitate easier intravascular sclerosing agent injection by dilating the varices and enhancing scope stability by maintaining low intra‐gastrointestinal pressure. Therefore, we aimed to evaluate the effectiveness and safety of this procedure. This retrospective study included 18 patients (14 men and four women; median age, 70 years; age range, 18–83 years) who underwent GI‐EIS at Osaka Medical Pharmaceutical University Hospital between December 1, 2022, and January 30, 2024. Patients who were at least 18 years of age at the time of treatment were included. No patients were excluded from the study. Thirty‐four punctures were performed. The donor vessel angiography success rate was 88.2% (30 of 34 punctures). The clinical success rate was 94.4% (17 of 18 patients). Esophageal varices in most patients disappeared or were reduced by 1 month after treatment. Adverse events related to the procedure included fever (three patients) and chest pain (one patient); however, both were resolved with conservative treatment. No respiratory deterioration due to aspiration occurred during the procedure. The results of this study demonstrate that GI‐EIS is a safe, clinically feasible, and effective treatment option for prophylactic hemostasis of esophageal varices.
- Open Access
A case of gastrolithiasis produced by a 5‐day diet
A 55‐year‐old man with a history of distal gastrectomy was admitted to our hospital due to gastrointestinal bleeding from an anastomotic ulcer. After endoscopic hemostasis, his oral intake resumed after 1 day of fasting; however, he could not ingest food because of early satiety and nausea on the fifth day of oral intake resumption. Esophagogastroduodenoscopy was performed again to investigate the cause of anorexia and revealed a massive gastrolithiasis that was not observed in the previous esophagogastroduodenoscopy, which was diagnosed as the cause of his anorexia. Gastrolithiasis was treated with endoscopic removal the day after diagnosis, and the patient was discharged from the hospital after his symptoms resolved. Herein, we report the case of a patient with gastrolithiasis that developed and proliferated within 5 days.
Open AccessA case of gastrolithiasis produced by a 5‐day diet
A 55‐year‐old man with a history of distal gastrectomy was admitted to our hospital due to gastrointestinal bleeding from an anastomotic ulcer. After endoscopic hemostasis, his oral intake resumed after 1 day of fasting; however, he could not ingest food because of early satiety and nausea on the fifth day of oral intake resumption. Esophagogastroduodenoscopy was performed again to investigate the cause of anorexia and revealed a massive gastrolithiasis that was not observed in the previous esophagogastroduodenoscopy, which was diagnosed as the cause of his anorexia. Gastrolithiasis was treated with endoscopic removal the day after diagnosis, and the patient was discharged from the hospital after his symptoms resolved. Herein, we report the case of a patient with gastrolithiasis that developed and proliferated within 5 days.
- Open Access
- 24 June 2024
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 12 (08) , E955-E961
Mechanical evaluation of the dilation force of dilation devices during interventional endoscopic ultrasound
Background and study aims To insert the metal stent delivery system (8.5F) during interventional endoscopic ultrasound (I-EUS), several dilation steps are needed, which may be related to increased bile leakage from a fistula. There have been no definitive studies of dilation force. The aim of the present study was to evaluate dilation force during I-EUS using several dilation devices. Methods In the present study, seven dilation devices were evaluated including bougie dilators such as a straight-shaped dilator (the ES dilator, Soehendra dilator, a standard ERCP catheter) a screw-shaped dilator (Tornus ES, Soehendra stent retriever), and a 4-mm balloon catheter (REN biliary balloon catheter, Hurricane RX). The diameter of each dilator and dilation force were measured. Results Of the bougie dilators, the dilation force of the ES dilator was the highest (0.908±0.035 kg). Of the balloon catheters, the dilation force of the Hurricane RX (3.261±0.024 kg) was slightly higher than that of the REN (3.159±0.072 kg). Of the bougie dilators, although the diameter of the ES dilator was not larger than that of the Tornus ES, the dilation force was stronger. Similarly, the diameter of the Soehendra stent retriever was greater than that of the ERCP catheter or Soehendra dilator and the dilation force was lower. Conclusions Compared with bougie dilators, balloon catheters have stronger dilation force according to our experimental study. The present results should be evaluated in clinical trials.
- 24 June 2024
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 12 (08) , E955-E961
Open AccessMechanical evaluation of the dilation force of dilation devices during interventional endoscopic ultrasound
Background and study aims To insert the metal stent delivery system (8.5F) during interventional endoscopic ultrasound (I-EUS), several dilation steps are needed, which may be related to increased bile leakage from a fistula. There have been no definitive studies of dilation force. The aim of the present study was to evaluate dilation force during I-EUS using several dilation devices. Methods In the present study, seven dilation devices were evaluated including bougie dilators such as a straight-shaped dilator (the ES dilator, Soehendra dilator, a standard ERCP catheter) a screw-shaped dilator (Tornus ES, Soehendra stent retriever), and a 4-mm balloon catheter (REN biliary balloon catheter, Hurricane RX). The diameter of each dilator and dilation force were measured. Results Of the bougie dilators, the dilation force of the ES dilator was the highest (0.908±0.035 kg). Of the balloon catheters, the dilation force of the Hurricane RX (3.261±0.024 kg) was slightly higher than that of the REN (3.159±0.072 kg). Of the bougie dilators, although the diameter of the ES dilator was not larger than that of the Tornus ES, the dilation force was stronger. Similarly, the diameter of the Soehendra stent retriever was greater than that of the ERCP catheter or Soehendra dilator and the dilation force was lower. Conclusions Compared with bougie dilators, balloon catheters have stronger dilation force according to our experimental study. The present results should be evaluated in clinical trials.
- Open Access
- 4 June 2024
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 12 (06) , E769-E771
The “Dumpling method:” Novel technique for preventing PuraStat migration and enhancing hemostasis
Received: 06 March 2024 Accepted after revision: 25 April 2024 Article published online: 20 June 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 4 June 2024
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 12 (06) , E769-E771
Open AccessThe “Dumpling method:” Novel technique for preventing PuraStat migration and enhancing hemostasis
Received: 06 March 2024 Accepted after revision: 25 April 2024 Article published online: 20 June 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 31 January 2024
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 12 (02) , E262-E268
Evaluation of exclusive internal endoscopic drainage for complex biloma with transluminal and transpapillary stenting
Background and study aims Biloma is treated endoscopically with endoscopic retrograde cholangiography (ERCP) or endoscopi ultrasound-guided transluminal biloma drainage (EUS-TBD). However, almost all previous studies have used both internal and external drainage. External drainage has the disadvantages of poor cosmetic appearance and self-tube removal. The aim of the present study was to evaluate the internal endoscopic drainage for complex biloma after hepatobiliary surgery with an ERCP- or EUS-guided approach, without external drainage. Patients and methods This retrospective study included consecutive patients who had bilomas. A 7F plastic stent was deployed from the biloma to the duodenum in the ERCP group and the metal stent was deployed from the biloma to the stomach in the EUS-TBD group. Results Forty-seven patients were enrolled. The technical success rate was similar between the groups (ERCP 94% vs EUS-TBD 100%, P=0.371); however, mean procedure time was significantly shorter in the EUS-TBD group (16.9 minutes) than in the ERCP group (26.6 minutes) (P=0.009). The clinical success rate was 87% (25 of 32 patients) in the ERCP group and 84% (11 of 13 patients) in the EUS-TBD group (P=0.482). The duration of median hospital stay was significantly shorter in the EUS-TBD group (22 days) than in the ERCP group (46 days) (P=0.038). There was no significant difference in procedure-associated adverse events between the groups. Conclusions In conclusion, ERCP and EUS-TBD are complementary techniques, each with its own merits in specific clinical scenarios. If both techniques can be performed, EUS-TBD should be considered because of the short times for the procedure, hospital stay. and biloma resolution.
- 31 January 2024
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 12 (02) , E262-E268
Open AccessEvaluation of exclusive internal endoscopic drainage for complex biloma with transluminal and transpapillary stenting
Background and study aims Biloma is treated endoscopically with endoscopic retrograde cholangiography (ERCP) or endoscopi ultrasound-guided transluminal biloma drainage (EUS-TBD). However, almost all previous studies have used both internal and external drainage. External drainage has the disadvantages of poor cosmetic appearance and self-tube removal. The aim of the present study was to evaluate the internal endoscopic drainage for complex biloma after hepatobiliary surgery with an ERCP- or EUS-guided approach, without external drainage. Patients and methods This retrospective study included consecutive patients who had bilomas. A 7F plastic stent was deployed from the biloma to the duodenum in the ERCP group and the metal stent was deployed from the biloma to the stomach in the EUS-TBD group. Results Forty-seven patients were enrolled. The technical success rate was similar between the groups (ERCP 94% vs EUS-TBD 100%, P=0.371); however, mean procedure time was significantly shorter in the EUS-TBD group (16.9 minutes) than in the ERCP group (26.6 minutes) (P=0.009). The clinical success rate was 87% (25 of 32 patients) in the ERCP group and 84% (11 of 13 patients) in the EUS-TBD group (P=0.482). The duration of median hospital stay was significantly shorter in the EUS-TBD group (22 days) than in the ERCP group (46 days) (P=0.038). There was no significant difference in procedure-associated adverse events between the groups. Conclusions In conclusion, ERCP and EUS-TBD are complementary techniques, each with its own merits in specific clinical scenarios. If both techniques can be performed, EUS-TBD should be considered because of the short times for the procedure, hospital stay. and biloma resolution.
- 7 August 2023
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 58 (11) , 1257-1259
Impact of HLA disparity on overall mortality risk in patients with extensive chronic GVHD: The HLA Working Group of Japanese Society for Transplantation and Cellular Therapy
- 7 August 2023
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 58 (11) , 1257-1259
Impact of HLA disparity on overall mortality risk in patients with extensive chronic GVHD: The HLA Working Group of Japanese Society for Transplantation and Cellular Therapy